Isogenic radiation resistant cell lines: Development and validation strategies

References

• Aylon Y, Oren M. 2011. p53: Guardian of ploidy. Molec Oncol 5: 315–323.
   PubMedGoogle Scholar
• Bai J, Guo XG, Bai XP. 2012. Epidermal growth factor receptor-related DNA repair and radiation-resistance regulatory mechanisms: A mini-review. Asian Pac J Cancer Prevent 13:4879–4881.
   PubMedGoogle Scholar
• Banath JP, Klokov D, MacPhail SH, Banuelos CA, Olive PL. 2010. Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer 10:4.
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN. 2006. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444:756–760.
   PubMed Web of Science ®Google Scholar
• Baumann M, Krause M, Thames H, Trott K, Daniel Z. 2009. Cancer stem cells and radiotherapy. Int J Radiat Biol 85:391–402.
   PubMed Web of Science ®Google Scholar
• Begg AC, Stewart FA, Vens C. 2011. Strategies to improve radiotherapy with targeted drugs. Nature Rev Cancer 11:239–253.
   PubMed Web of Science ®Google Scholar
• Boivin A, Hanot M, Malesys C, Maalouf M, Rousson R, Rodriguez-Lafrasse C, Ardail D. 2011. Transient alteration of cellular redox buffering before irradiation triggers apoptosis in head and neck carcinoma stem and non-stem cells. PLoS ONE 6:e14558.
   Google Scholar
• Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. 2008. GammaH2AX and cancer. Nature Rev Cancer 8:957–967.
   PubMedGoogle Scholar
• Brieger J, Kattwinkel J, Berres M, Gosepath J, Mann WJ. 2007. Impact of vascular endothelial growth factor release on radiation resistance. Oncol Reports 18:1597–1601.
   PubMed Web of Science ®Google Scholar
• Bristow RG, Hill RP. 2008. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nature Rev Cancer 8:180–192.
   PubMed Web of Science ®Google Scholar
• Bristow RG, Ozcelik H, Jalali F, Chan N, Vesprini D. 2007. Homologous recombination and prostate cancer: A model for novel DNA repair targets and therapies. Radiother Oncol 83:220–230.
   PubMed Web of Science ®Google Scholar
• Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB. 1987. Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of radiosensitivity. Cancer Res 47:943–946.
   PubMed Web of Science ®Google Scholar
• Castedo M, Coquelle A, Vivet S, Vitale I, Kauffmann A, Dessen P, Pequignot MO, Casares N, Valent A, Mouhamad S, et al. 2006. Apoptosis regulation in tetraploid cancer cells. Embo J 25: 2584–2595.
   PubMed Web of Science ®Google Scholar
• Chalmers AJ, Lakshman M, Chan N, Bristow RG. 2010. Poly(ADP- ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets. Semin Radiat Oncol 20: 274–281.
   PubMed Web of Science ®Google Scholar
• Cho YM, Kim YS, Kang MJ, Farrar WL, Hurt EM. 2012. Long-term recovery of irradiated prostate cancer increases cancer stem cells. Prostate 72:1746–1756.
   PubMedGoogle Scholar
• Davoli T, de Lange T. 2011. The causes and consequences of polyploidy in normal development and cancer. Ann Rev Cell Develop Biol 27:585–610.
   PubMed Web of Science ®Google Scholar
• De Llobet LI, Baro M, Figueras A, Modolell I, Da Silva MV, Munoz P, Navarro A, Mesia R, Balart J. 2012. Development and characterization of an isogenic cell line with a radioresistant phenotype. Clin Translat Oncol 15:189–197.
   PubMedGoogle Scholar
• De Pooter CMJ, Scalliet PG, Elst HJ, Huybrechts JJ, Gheuens EEO, Van Oosterom AT, Fichtinger-Shepman AJ, De Bruijn A. 1991. Resistance patterns between cis-Diamminedichloroplatinum(II) and ionizing radiation. Cancer Res 51:452–4527.
   Google Scholar
• Denizot F, Lang R. 1986. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability.J Immunolog Meth 89:271–277.
   PubMed Web of Science ®Google Scholar
• Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, Qian D, Lam JS, Ailles LE, Wong M, et al. 2009. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458:780–783.
   PubMed Web of Science ®Google Scholar
• Dumont FJ, Bischoff P. 2012. Disrupting the mTOR signaling network as a potential strategy for the enhancement of cancer radiotherapy. Curr Cancer Drug Targ 12:899–924.
   PubMed Web of Science ®Google Scholar
• Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nature Protoc 1:2315–2319.
   PubMed Web of Science ®Google Scholar
• Fujii J, Ikeda Y. 2002. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7:123–130.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y, Hagiwara A, Mitsufuji S, Okazaki Y, Hayashizaki Y, et al. 2004. Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer 91:1543–1550.
   PubMed Web of Science ®Google Scholar
• Ganem NJ, Pellman D. 2007. Limiting the proliferation of polyploid cells. Cell 131:437–440.
   Google Scholar
• Gao X, McDonald JT, Hlatky L, Enderling H. 2013. Acute and fractionated irradiation differentially modulate glioma stem cell division kinetics. Cancer Res 73:1481–1490.
   PubMed Web of Science ®Google Scholar
• Harveie RM, Davey MW, Davey RA. 1997. Increased mrp expression is associated with resistance to radiation, anthracyclines and etoposide in cells treated with fractionated λ-radiation. Int J Cancer 73:164–167.
   PubMedGoogle Scholar
• Henness S, Davey MW, Harvie RM, Davey RA. 2002. Fractionated irradiation of H69 small-cell lung cancer cells causes stable radiation and drug resistance with increased MRP1, MRP2, and topoisomerase IIalpha expression. Int J Radiat Oncol Biol Phys 54:895–902.
   PubMed Web of Science ®Google Scholar
• Henness S, Davey MW, Harvie RM, Banyer J, Wasinger V, Corthals G, Davey RA. 2004. Changes in gene expression associated with stable drug and radiation resistance in small cell lung cancer cells are similar to those caused by a single X-ray dose. Radiat Res 161:495–503.
   PubMedGoogle Scholar
• Illidge TM, Cragg MS, Fringes B, Olive P, Erenpreisa JA. 2000. Polyploid giant cells provide a survival mechanism for p53 mutant cells after DNA damage. Cell Biol Int 24:621–633.
   PubMed Web of Science ®Google Scholar
• Illum H. 2012. Current status of radiosensitizing agents for the management of rectal cancer. Crit Rev Oncogenesis 17:345–359.
   PubMedGoogle Scholar
• Insinga A, Cicalese A, Faretta M, Gallo B, Albano L, Ronzoni S, Furia L, Viale A, Pelicci PG. 2013. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions. Proc Nat Acad Sci USA 110:3931–3936.
   PubMed Web of Science ®Google Scholar
• Joiner M, van der Kogel A. 2008. Basic clinical radiobiology. 4th ed. London, Hodder Arnold.375 p.
   Google Scholar
• Kabolizadeh P, Kubicek GJ, Heron DE, Ferris RL, Gibson MK. 2012. The role of cetuximab in the management of head and neck cancers. Expert Opin Biologic Ther 12:517–528.
   PubMed Web of Science ®Google Scholar
• Ke CC, Liu RS, Yang AH, Liu CS, Chi CW, Tseng LM, Tsai YF, Ho JH, Lee CH, Lee OK. 2013. CD133-expressing thyroid cancer cells are undifferentiated, radioresistant and survive radioiodide therapy. Eur J Nuclear Med Molec Imaging 40:61–71.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee SY, Park HR, Sung JM, Park AR, Kang S, Kim BG, Choi YP, Kim YB, Cho NH. 2011. Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. Cancer 117:1864–1873.
   PubMed Web of Science ®Google Scholar
• Krause M, Yaromina A, Eicheler W, Koch U, Baumann M. 2011. Cancer stem cells: Targets and potential biomarkers for radiotherapy. Clin Cancer Res 17:7224–7229.
   PubMed Web of Science ®Google Scholar
• Krueger SA, Wilson GD. 2011. Flow cytometric DNA analysis of human cancers and cell lines. Methods Molec Biol 731:359–370.
   PubMedGoogle Scholar
• Kuger S, Graus D, Brendtke R, Gunther N, Katzer A, Lutyj P, Polat B, Chatterjee M, Sukhorukov VL, Flentje M, et al. 2013. Radiosensitization of glioblastoma cell lines by the dual PI3K and mTOR inhibitor NVP-BEZ235 depends on drug-irradiation schedule. Translat Oncol 6:169–179.
   PubMedGoogle Scholar
• Kuwahara Y, Li L, Baba T, Nakagawa H, Shimura T, Yamamoto Y, Ohkubo Y, Fukumoto M. 2009. Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays. Cancer Sci 100:747–752.
   PubMedGoogle Scholar
• Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F. 2010. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res 12:R13.
   PubMed Web of Science ®Google Scholar
• Lee JU, Hosotani R, Wada M, Doi R, Kosiba T, Fujimoto K, Miyamoto Y, Tsuji S, Nakajima S, Nishimura Y, et al. 1999. Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer 35:1374–1380.
   PubMed Web of Science ®Google Scholar
• Lee SY, Park HR, Cho NH, Choi YP, Rha SY, Park SW, Kim SH. 2013. Identifying genes related to radiation resistance in oral squamous cell carcinoma cell lines. Int J Oral Maxillofacial Surg 42:169–176.
   PubMedGoogle Scholar
• Lee YS, Oh JH, Yoon S, Kwon MS, Song CW, Kim KH, Cho MJ, Mollah ML, Je YJ, Kim YD, et al. 2010. Differential gene expression profiles of radioresistant non-small-cell lung cancer cell lines established by fractionated irradiation: Tumor protein p53-inducible protein 3 confers sensitivity to ionizing radiation. Int J Radiat Oncol Biol Phys 77:858–866.
   PubMed Web of Science ®Google Scholar
• Liang K, Ang KK, Milas L, Hunter N, Fan Z. 2003. The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 57:246–254.
   PubMed Web of Science ®Google Scholar
• Lim YC, Roberts TL, Day BW, Harding A, Kozlov S, Kijas AW, Ensbey KS, Walker DG, Lavin MF. 2012. A role for homologous recombination and abnormal cell-cycle progression in radioresistance of glioma-initiating cells. Molec Cancer Ther 11:1863–1872.
   PubMedGoogle Scholar
• Lynam-Lennon N, Reynolds JV, Pidgeon GP, Lysaght J, Marignol L, Maher SG. 2010. Alterations in DNA Repair efficiency are involved in the radioresistance of esophageal adenocarcinoma. Radiat Res 174:703–711.
   PubMed Web of Science ®Google Scholar
• MacPhail SH, Banath JP, Yu TY, Chu EH, Lambur H, Olive PL. 2003. Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol 79:351–358.
   PubMed Web of Science ®Google Scholar
• Mihatsch J, Toulany M, Bareiss PM, Grimm S, Lengerke C, Kehlbach R, Rodemann HP. 2011. Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro. Radiother Oncol 99:300–306.
   PubMed Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 65:55–63.
   PubMed Web of Science ®Google Scholar
• Nair JS, Ho AL, Schwartz GK. 2012. The induction of polyploidy or apoptosis by the Aurora A kinase inhibitor MK8745 is p53-dependent. Cell Cycle 11:807–817.
   PubMed Web of Science ®Google Scholar
• Nguyen GH, Murph MM, Chang JY. 2011. Cancer stem cell radioresistance and enrichment: Where frontline radiation therapy may fail in lung and esophageal cancers. Cancers (Basel) 3:1232–1252.
   PubMedGoogle Scholar
• Otto K. 2008. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 35:310–317.
   PubMed Web of Science ®Google Scholar
• Pajonk F, Vlashi E, McBride WH. 2010. Radiation resistance of c ancer stem cells: The 4 Rs of radiobiology revisited. Stem Cells 28:639–648.
   PubMed Web of Science ®Google Scholar
• Park JJ, Chang HW, Jeong EJ, Roh JL, Choi SH, Jeon SY, Ko GH, Kim SY. 2009. Peroxiredoxin IV protects cells from radiation-induced apoptosis in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 73:1196–1202.
   PubMedGoogle Scholar
• Park SH, Chung YM, Lee YS, Kim HJ, Kim JS, Chae HZ, Yoo YD. 2000. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin Cancer Res 6:4915–4920.
   PubMed Web of Science ®Google Scholar
• Pavelic K, Kapitanovic S, Radosevic S, Bura M, Seiwerth S, Pavelic LJ, Unusic J, Spaventi R. 2000. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis. J Molec Med (Berlin) 78:111–118.
   PubMedGoogle Scholar
• Pawlik TM, Keyomarsi K. 2004. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928–942.
   PubMed Web of Science ®Google Scholar
• Phillips TM, McBride WH, Pajonk F. 2006. The response of CD24(2/low)/CD44 + breast cancer-initiating cells to radiation. J Nat Cancer Inst 98:1777–1785.
   PubMed Web of Science ®Google Scholar
• Potiron VA, Abderrhamani R, Giang E, Chiavassa S, Di Tomaso E, Maira SM, Paris F, Supiot S. 2013. Radiosensitization of prostate cancer cells by the dual PI3K/mTOR inhibitor BEZ235 under normoxic and hypoxic conditions. Radiother Oncol 106:138–146.
   PubMedGoogle Scholar
• Price P, McMillan TJ. 1990. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation. Cancer Res 50:1392–1396.
   PubMed Web of Science ®Google Scholar
• Printz C. 2012. Radiation treatment generates therapy-resistant cancer stem cells from less aggressive breast cancer cells. Cancer 118:3225.
   Google Scholar
• Raffoul JJ, Banerjee S, Singh-Gupta V, Knoll ZE, Fite A, Zhang H, Abrams J, Sarkar FH, Hillman GG. 2007. Down-regulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 expression by soy isoflavones enhances prostate cancer radiotherapy in vitro and in vivo. Cancer Res 67:2141–2149.
   PubMed Web of Science ®Google Scholar
• Ree AH, Hollywood D. 2013. Design and conduct of early-phase radiotherapy trials with targeted therapeutics: Lessons from the PRAVO experience. Radiother Oncol 108:3–16.
   PubMedGoogle Scholar
• Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. 1998. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biologic Chem 273:5858–5868.
   PubMed Web of Science ®Google Scholar
• Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, et al. 2000. Systematic variation in gene expression patterns in human cancer cell lines. Nature Genet 24:227–235.
   PubMed Web of Science ®Google Scholar
• Russel J, Wheldon TE, Stanton P. 1995. A radioresistant variant derived from a human neurblstoma cell line is less prone to radiation- induce apoptosis. Cancer Res 55:4915–4921.
   PubMedGoogle Scholar
• Ruutu M, Johansson B, Grenman R, Syrjanen K, Syrjanen S. 2004. Effect of confluence state and passaging on global cancer gene expression pattern in oral carcinoma cell lines. Anticancer Res 24:2627–2632.
   PubMedGoogle Scholar
• Sak A, Stuschke M, Groneberg M, Kubler D, Pottgen C, Eberhardt WE. 2012. Inhibiting the aurora B kinase potently suppresses repopulation during fractionated irradiation of human lung cancer cell lines. Int J Radiat Oncol Biol Phys 84:492–499.
   PubMed Web of Science ®Google Scholar
• Sandberg R, Ernberg I. 2005. Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Nat Acad Sci USA 102:2052–2057.
   PubMed Web of Science ®Google Scholar
• Sinclair WK, Morton RA. 1966. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res 29: 450–474.
   PubMed Web of Science ®Google Scholar
• Skvortsova I, Skvortsov S, Stasyk T, Raju U, Popper BA, Schiestl B, von Guggenberg E, Neher A, Bonn GK, Huber LA, et al. 2008. Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics 8: 4521–4533.
   Google Scholar
• Smith-Pearson PS, Kooshki M, Spitz DR, Poole LB, Zhao W, Robbins ME. 2008. Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2). Free Rad Biol Med 45: 1178–1189.
   PubMed Web of Science ®Google Scholar
• Smith L, Qutob O, Watson MB, Beavis AW, Potts D, Welham KJ, Garimella V, Lind MJ, Drew PJ, Cawkwell L. 2009. Proteomic identification of putative biomarkers of radiotherapy resistance: A possible role for the 26S proteasome?Neoplasia 11:1194–1207.
   PubMed Web of Science ®Google Scholar
• Smith RP, Heron DE, Huq MS, Yue NJ. 2006. Modern radiation treatment planning and delivery – from Rontgen to real time. Hematol Oncol Clin N Am 20:45–62.
   PubMedGoogle Scholar
• Tao Y, Leteur C, Calderaro J, Girdler F, Zhang P, Frascogna V, Varna M, Opolon P, Castedo M, Bourhis J, et al. 2009. The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe. Cell Cycle 8:3172–3181.
   PubMed Web of Science ®Google Scholar
• Vlashi E, McBride WH, Pajonk F. 2009. Radiation responses of cancer stem cells. J Cell Biochem 108:339–342.
   PubMed Web of Science ®Google Scholar
• Wang Q, Wu PC, Dong DZ, Ivanova I, Chu E, Zeliadt S, Vesselle H, Wu DY. 2013a. Polyploidy road to therapy-induced cellular senescence and escape. Int J Cancer 132:1505–1515.
   Google Scholar
• Wang T, Tamae D, LeBon T, Shively JE, Yen Y, Li JJ. 2005. The role of peroxiredoxin II in radiation-resistant MCF-7 breast cancer cells. Cancer Res 65:10338–10346.
   PubMedGoogle Scholar
• Wang WJ, Wu SP, Liu JB, Shi YS, Huang X, Zhang QB, Yao KT. 2013b. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells. Cancer Res 73:1219–1231.
   PubMed Web of Science ®Google Scholar
• Wang X, Ma Z, Xiao Z, Liu H, Dou Z, Feng X, Shi H. 2012. Chk1 knockdown confers radiosensitization in prostate cancer stem cells. Oncol Rep 28:2247–2254.
   PubMed Web of Science ®Google Scholar
• Wang YF, Chow KC, Chang SY, Chiu JH, Tai SK, Li WY, Wang LS. 2004. Prognostic significance of nm23-H1 expression in oral squamous cell carcinoma. Br J Cancer 90:2186–2193.
   PubMedGoogle Scholar
• Wei Q-C, Shen L, Zheng S, Zhu Y-L. 2008. Isolation and characterization of radiation-resistant lung cancer d6-r cell line. Biomed Environ Sci 21:339–344.
   PubMedGoogle Scholar
• Wenger SL, Senft JR, Sargent LM, Bamezai R, Bairwa N, Grant SG. 2004. Comparison of established cell lines at different passages by karyotype and comparative genomic hybridization. Biosci Rep 24:631–639.
   PubMed Web of Science ®Google Scholar
• Wu J, Lai G, Wan F, Xiao Z, Zeng L, Wang X, Ye F, Lei T. 2012. Knockdown of checkpoint kinase 1 is associated with the increased radiosensitivity of glioblastoma stem-like cells. Tohoku J Experim Med 226:267–274.
   PubMed Web of Science ®Google Scholar
• Xia P, Gou WF, Wang JJ, Niu ZF, Chen S, Takano Y, Zheng HC. 2013. Distinct radiosensitivity of lung carcinoma stem-like side population and main population cells. Cancer Biother Radiopharmaceut 28:471–478.
   PubMed Web of Science ®Google Scholar
• Xie L, Song X, Yu J, Wei L, Bao Song, Wang X, Lv L. 2009. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. J Experim Clin Cancer Res 28:68.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhang Y, Ma S. 2011. EGFR inhibitors with concurrent thoracic radiation therapy for locally advanced non-small cell lung cancer. Lung Cancer 73:249–255.
   PubMedGoogle Scholar
• Zhang X, Komaki R, Wang L, Fang B, Chang JY. 2008. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clinical Cancer Res 14:2813–2823.
   PubMedGoogle Scholar